|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Accretion of discount on marketable securities, net | |||||
| Amortization of right-of-use asset | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Accrued other expenses and other liabilities | |||||
| Lease liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Purchases of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Exercise of stock options | |||||
| Payment of deferred offering costs | |||||
| Proceeds from Employee Stock Purchase Plan | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Right-of-use asset obtained in exchange for new operating lease liability, net of tenant improvement receivable | |||||
| Property and equipment purchases included in accounts payable and accrued other expenses | |||||
Loading...